News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Link David Charles
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/09/2022 |
4
| Link David Charles (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 41,493 shares
@ $1.205, valued at
$50k
Granted 41,493 options to buy
@ $1.08, valued at
$44.8k
|
|
| 10/26/2021 |
4
| Link David Charles (Director) has filed a Form 4 on SAB Biotherapeutics, Inc.|
Txns:
| Granted 15,820 shares
@ $0
Granted 12,097 shares
@ $0
Granted 6,391 options to buy
@ $0
Granted 4,887 options to buy
@ $0
Granted 23,264 options to buy
@ $1, valued at
$23.3k
Granted 69,793 options to buy
@ $1.25, valued at
$87.2k
Granted 17,231 options to buy
@ $0 |
|
| 10/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|